RxDoctor Payments Data

Alison Alexander, MD

Geriatric Medicine · Narbeth, PANPI 1215096243

Payments from drug & device makers

$310in general payments, 2019–2025

Across 15 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$133
  • AstraZeneca$68
  • Sunovion Pharmaceuticals Inc.$50
  • Neurocrine Biosciences, Inc.$21
  • Avanir Pharmaceuticals, Inc.$20
  • UCB, Inc.$18

What the payments were for

  • Food & beverage$310100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$310 in reported general payments places this provider in the 65th percentile of 217 geriatric medicine providers in Pennsylvania.

See all geriatric medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$250,627
Medicare patients
429
Services billed
2,034

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban837$247,765
FarxigaDapagliflozin Propanediol170$55,967
BiktarvyBictegrav/Emtricit/Tenofov Ala12$50,501
TrulicityDulaglutide54$48,293
SantylCollagenase Clostridium Hist.23$46,630
EntrestoSacubitril/Valsartan110$37,662
XareltoRivaroxaban109$29,814
TivicayDolutegravir Sodium11$25,896
CopaxoneGlatiramer Acetate16$24,689
Atorvastatin Calcium1,239$22,548
Risperdal ConstaRisperidone Microspheres17$22,255
LokelmaSodium Zirconium Cyclosilicate46$19,878
TradjentaLinagliptin69$18,254
JardianceEmpagliflozin47$14,750
Memantine Hcl255$14,376

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Lokelma$68$75,845216 claims
Sunovion Pharmaceuticals Inc.Aptiom$50$13,88523 claims
Sumitomo Pharma America, Inc.Gemtesa$133$6,26828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 217 geriatric medicine providers in Pennsylvania.

Other geriatric medicine in Narbeth

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →